BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 11224476)

  • 1. Antagonism of amphetamine-induced disruption of latent inhibition by the atypical antipsychotic olanzapine in rats.
    Gosselin G; Oberling P; Di Scala G
    Behav Pharmacol; 1996 Dec; 7(8):820-826. PubMed ID: 11224476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The sigma ligand BMY-14802 as a potential antipsychotic: evidence from the latent inhibition model in rats.
    Weiner I; Traub A; Rawlins JN; Smith AD; Feldon J
    Behav Pharmacol; 1995 Jan; 6(1):46-54. PubMed ID: 11224311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The latent inhibition model of schizophrenia: further validation using the atypical neuroleptic, clozapine.
    Weiner I; Shadach E; Tarrasch R; Kidron R; Feldon J
    Biol Psychiatry; 1996 Nov; 40(9):834-43. PubMed ID: 8896769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amphetamine-induced disruption of latent inhibition depends on the nature of the stimulus.
    Weiner I; Bernasconi E; Broersen LM; Feldon J
    Behav Pharmacol; 1997 Oct; 8(5):442-57. PubMed ID: 9832983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of clozapine on latent inhibition in the rat.
    Moran PM; Fischer TR; Hitchcock JM; Moser PC
    Behav Pharmacol; 1996 Jan; 7(1):42-48. PubMed ID: 11224392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic administration of MK-801 produces an abnormally persistent latent inhibition which is reversed by clozapine but not haloperidol.
    Gaisler-Salomon I; Weiner I
    Psychopharmacology (Berl); 2003 Apr; 166(4):333-42. PubMed ID: 12599023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early handling and latent inhibition in the conditioned suppression paradigm.
    Weiner I; Feldon J; Ziv-Harris D
    Dev Psychobiol; 1987 Mar; 20(2):233-40. PubMed ID: 3582782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of the new antipsychotic, sertindole, on latent inhibition in rats.
    Weiner I; Kidron R; Tarrasch R; Arnt J; Feldon J
    Behav Pharmacol; 1994 Apr; 5(2):119-124. PubMed ID: 11224259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of microinjections of apomorphine and haloperidol into the inferior colliculus on the latent inhibition of the conditioned emotional response.
    Melo LL; Pereira EC; Pagini CH; Coimbra NC; Brandão ML; Ferrari EA
    Exp Neurol; 2009 Mar; 216(1):16-21. PubMed ID: 19084523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disruption and potentiation of latent inhibition by risperidone: the latent inhibition model of atypical antipsychotic action.
    Weiner I; Schiller D; Gaisler-Salomon I
    Neuropsychopharmacology; 2003 Mar; 28(3):499-509. PubMed ID: 12629529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haloperidol- and clozapine-induced enhancement of latent inhibition with extended conditioning: implications for the mechanism of action of neuroleptic drugs.
    Weiner I; Shadach E; Barkai R; Feldon J
    Neuropsychopharmacology; 1997 Jan; 16(1):42-50. PubMed ID: 8981387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haloperidol-induced potentiation of latent inhibition: interaction with parameters of conditioning.
    Ruob C; Weiner I; Feldon J
    Behav Pharmacol; 1998 May; 9(3):245-53. PubMed ID: 9832938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contrasting effects of diazepam and repeated restraint stress on latent inhibition in mice.
    Mongeau R; Marcello S; Andersen JS; Pani L
    Behav Brain Res; 2007 Nov; 183(2):147-55. PubMed ID: 17629580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of apomorphine and clozapine on conditioned freezing and latent inhibition.
    Masson S; Avanzi V; Troncoso AC; Brandão ML
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Sep; 27(6):935-43. PubMed ID: 14499310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Latent inhibition is not affected by acute or chronic administration of 6 mg/kg dl-amphetamine.
    Weiner I; Izraeli-Telerant A; Feldon J
    Psychopharmacology (Berl); 1987; 91(3):345-51. PubMed ID: 3104957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disruption of latent inhibition to a contextual stimulus with systemic amphetamine.
    Norman C; Cassaday HJ
    Neurobiol Learn Mem; 2004 Jul; 82(1):61-4. PubMed ID: 15183172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amphetamine-induced disruption and haloperidol-induced potentiation of latent inhibition depend on the nature of the stimulus.
    Ruob C; Elsner J; Weiner I; Feldon J
    Behav Brain Res; 1997 Oct; 88(1):35-41. PubMed ID: 9401706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of phencyclidine on latent inhibition in taste aversion conditioning: differential effects of preexposure and conditioning.
    Pålsson E; Klamer D; Wass C; Archer T; Engel JA; Svensson L
    Behav Brain Res; 2005 Feb; 157(1):139-46. PubMed ID: 15617780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abolition of the expression but not the acquisition of latent inhibition by chronic amphetamine in rats.
    Weiner I; Lubow RE; Feldon J
    Psychopharmacology (Berl); 1984; 83(2):194-9. PubMed ID: 6431473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Basolateral amygdala lesions do not disrupt latent inhibition.
    Weiner I; Tarrasch R; Feldon J
    Behav Brain Res; 1995 Dec; 72(1-2):73-81. PubMed ID: 8788859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.